Evidence map›Paper›PMID 39695164›Full record

ArticleCell death & disease2024

Dual functions of silibinin in attenuating aortic dissection via regulating iron homeostasis and endoplasmic reticulum stress against ferroptosis.

Zhen Qi, Qiu-Guo Wang, Meng-Xi Huang, Yi-Fan Zeng, Jing-Yu Li, Zhi-Cheng Duan, Ling Tan, Hao Tang

Abstract read
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Smad3 Mediates Renal Fibrosis via GPX4-Dependent Ferroptosis.International journal of biological sciences · 2025
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhen Qi *Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China.ORCID 0000-0002-4687-5422
Qiu-Guo Wang *Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China.
Meng-Xi HuangJinshan Hospital, Fudan University, Shanghai, China.
Yi-Fan ZengDepartment of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China.
Jing-Yu LiDepartment of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China.
Zhi-Cheng DuanDepartment of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China.
Ling TanDepartment of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China. dr.tanling@csu.edu.cn.ORCID 0000-0002-8779-0169
Hao TangDepartment of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, China. dr.tanghao@csu.edu.cn.ORCID 0000-0003-2202-0515

Funding

Hunan Provincial Innovation Foundation for Postgraduate CX20230284Natural Science Foundation of Hunan Province (Hunan Provincial Natural Science Foundation) 2024JJ3042
6 · The paper itself

Abstract

Aortic dissection (AD) poses a significant threat to cardiovascular health globally, yet its underlying mechanisms remain elusive. Smooth muscle cells death and phenotypic switching are critically important pathological processes in AD. Currently, no pharmacological therapies have proven effective in managing AD. This study aims to elucidate the involvement of ferroptosis in AD progression and explore ferroptosis inhibition as a potential therapeutic approach for AD management. Elevated expression of ferroptosis markers (HMOX1, ACSL4, and 4-HNE) was observed in AD patients and β-Aminopropionitrile (BAPN)-induced mice. In vivo administration of silibinin (SIL) attenuated aortic dilation, inflammation, mitochondrial injury, and ferroptosis. SIL treatment enhanced cell viability and mitochondrial function while reducing reactive oxygen species (ROS) generation and mitigating ferroptosis in primary human aortic smooth muscle cells (HASMCs) induced by RSL3 or IKE. Mechanistically, RNA-sequencing analysis identified dysregulation of iron homeostasis and endoplasmic reticulum stress, which were modulated by SIL. Molecular docking, cellular thermal shift assay, drug affinity responsive target stability, and surface plasmon resonance analysis confirmed HMOX1 as a direct target of SIL, highlighting its role in modulating iron homeostasis. Moreover, NCT-502, a PHGDH inhibitor, reversed the protective effect of SIL in RSL3-induced HASMCs. Conversely, 4-PBA and ZnPP demonstrate a facilitative role. This suggests that SIL plays a crucial role in ferroptosis development by modulating iron homeostasis and endoplasmic reticulum stress-mediated serine biosynthesis, both in vitro and in vivo. Iron homeostasis and endoplasmic reticulum stress of HASMCs drive the development of aortic dissection. These findings unveil a novel role of SIL in mitigating ferroptosis in HASMCs, offering a promising therapeutic avenue for treating AD.

Indexed as

Aortic DissectionEndoplasmic Reticulum StressFerroptosisIronSilybinAnimalsFemaleHomeostasisHumansMaleMiceMice, Inbred C57BLMyocytes, Smooth MuscleReactive Oxygen SpeciesIronReactive Oxygen SpeciesSilybin

Identifiers

PMID39695164
PMCPMC11655547

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.